Loading
Congressmen support FDA protocol for abortion pill
By Michelle Bauman
Speaker of the House John Boehner. Credit: Gage Skidmore (CC BY-SA 2.0).
Speaker of the House John Boehner. Credit: Gage Skidmore (CC BY-SA 2.0).

.- Nearly 20 members of Congress voiced their support for an Ohio law regulating the use of the abortion drug RU-486 in compliance with U.S. Food and Drug Administration protocol.

The legislators backed the law in a brief filed in the Sixth Circuit Court of Appeals, which would prohibit abortion providers from encouraging women to use RU-486 in “off-label” ways that have not been approved by the FDA.

“Eight women in the U.S. have died from bacterial infection following the misuse of RU-486 – a misuse advocated by Planned Parenthood,” said Dr. Charmaine Yoest, president of Americans United for Life, in a Jan. 10 statement.

“Ohio’s law is simply a medical regulation aimed at promoting the safest use of a drug, as it was approved to be used by the FDA,” she added.

Americans United for Life filed the brief on behalf of Speaker of the House John Boehner (R-OH) and U.S. senator Tom Coburn, M.D. (R-OK), along with nine other U.S. representatives from Ohio and seven other representatives with medical backgrounds from around the country.

The brief was filed in a federal case involving an Ohio regulation requiring RU-486 – also known as mifepristone or Mifeprex – to be administered according to FDA recommendations.

Planned Parenthood has challenged the constitutionality of the law, arguing that it is too vague, violates women’s bodily integrity and places an “undue burden” on their “right” to abortion.

But according to the brief, medical regulations are necessary to “protect women from the dangerous off-label use” of RU-486, a drug regimen that – according to the FDA – has killed 14 women and injured more than 2,000 others.

Lower courts have upheld the law, which does not ban the drug, but simply requires that it “be administered in the way deemed safest by the FDA.”

According to the brief, Planned Parenthood has acknowledged that “abortion providers routinely administer RU-486 in a number of ways that fall outside the safety guidelines” established by the food and drug administration.

Such “off-label uses” include administering the drug after the seventh week of pregnancy; failing to examine women before and after taking the drug; and administering the regimen’s second drug – misoprostol – vaginally rather than orally.

The brief said that precedent indicates that “states are given wide discretion to legislate in areas where there is medical and scientific uncertainty.”

Even when used properly, the RU-486 drug regimen is dangerous, it argued. The drug label notes that nearly all women who take it “will report adverse reactions.”

A 2011 report issued by the FDA recorded 2,207 complications in the U.S. related to the use of RU-486, including 14 deaths, 339 blood transfusions, 612 hospitalizations and 256 infections.

Such a risky drug should be carefully regulated in order to “protect the health and welfare of women,” said the brief.

It argued that “potentially 10 out of the 14 reported U.S. deaths could possibly have been prevented” if the mifepristone had been properly administered according to FDA protocol.

The court of appeals will decide the fate of the Ohio bill, which has been tested in a series of courts since its 2004 approval by state legislature.

Yoest explained that the law is important because “women’s lives hang in the balance.”

“Requiring the proper distribution of drugs should be an area of bipartisan agreement,” she said.


Ads by AdsLiveMedia(What's this?)

* The number of messages that can be online is limited. CNA reserves the right to edit messages for content and tone. Comments and opinions expressed by users do not necessarily reflect the opinions or beliefs of CNA. CNA will not publish comments with abusive language, insults or links to other pages

RESOURCES »

Ads by Google (What's this?)
Ads by Google (What's this?)

Featured Videos

Pope Francis celebrates the closing Mass and announces site of next World Youth Day
Pope Francis celebrates the closing Mass and announces site of next World Youth Day
Pope Francis visits poor neighborhood and meets with young people from Argentina
Pope Francis celebrates Mass at the National Shrine of Our Lady of Aparecida
Denver rally draws hundreds in support of religious freedom
Pope Francis prays over a sick man in St Peter's Square
Denver women's clinic will offer natural, Catholic care
Interview Clips: Barbara Nicolosi speaks to CNA
US Cardinals press conference at North American College
Pope Benedict to retire to monastery inside Vatican City
Pope cites waning strength as reason for resignation
Hundreds convene in Denver to urge respect for life
New Orange bishop encourages Catholic unity in diversity
Chinese pro-life activist calls for reform, international attention
At Lincoln installation, Bishop Conley says holiness is success
Mother Cabrini shrine reopens in Chicago after a decade
Ordination of 33 deacons fills St. Peter's with joy
Cardinal says "Charity is the mother of all the virtues"
Augustine Institute expands evangelization effort with new campus
Bishops recall 'Way of St. James' as chance to trust in God
Los Angeles cathedral's newest chapel houses Guadalupe relic
Apr
15

Liturgical Calendar

April 15, 2014

Tuesday of Holy Week

All readings:
Today »
This year »

Catholic Daily

Gospel of the Day

Jn 13:21-33, 36-38

Gospel
Date
04/14/14
04/13/14

Daily Readings


Saint of the Day

St. Peter Gonzalez »

Saint
Date
04/14/14
04/13/14

Homily of the Day

Jn 13:21-33, 36-38

Homily
Date
04/14/14
04/13/14

Ads by AdsLiveMedia.com

Ads by AdsLiveMedia.com
     HTML
Text only
Headlines
  

Follow us: